Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech
Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox.
Read MoreStay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox.
Read MoreArtificial intelligence is making it easier to build apps, but it may take longer to get them on the App
Read MoreThis as-told-to essay is based on a conversation with Dr. Majid Fotuhi, a neurologist and adjunct professor at Johns Hopkins
Read MoreKinetic services cars attached with sensors that will be critical for an autonomous future. Courtesy Kinetic Modern cars are equipped
Read MoreIn this podcast, Motley Fool personal finance expert Robert Brokamp offers eight suggestions for making your portfolio last until you
Read MoreInvesting.com — Geopolitical risk in the Middle East has entered a new phase after Iran’s Islamic Revolutionary Guard Corps (IRGC)
Read MoreOperator Good evening, and welcome to the Boston Scientific American College of Cardiology Conference Call. [Operator Instructions] Please note, this
Read MoreThis article was written by Follow I’ve been researching companies in-depth for over a decade, from commodities like oil, natural
Read MoreThis article was written by Follow I’m an individual investor looking to grow my wealth over the long term. I’ve
Read MoreThere was a time when Roth 401(k)s were not so easy to find. But these days, many employer-sponsored 401(k) plans
Read More